- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Argininosuccinate Synthetase 1 Antibody / ASS1 Polyclonal Antibody targets argininosuccinate synthetase 1 (ASS1), a cytosolic enzyme involved in the urea cycle and the biosynthesis of arginine. ASS1 catalyzes the ATP-dependent reaction between citrulline and aspartate to produce argininosuccinate, an intermediate required for nitrogen disposal and arginine production. This reaction connects amino acid metabolism with pathways responsible for maintaining nitrogen balance and supporting cellular biosynthetic requirements.
Within the hepatic urea cycle, ASS1 functions downstream of ornithine transcarbamylase and upstream of argininosuccinate lyase (ASL). The argininosuccinate produced by ASS1 is subsequently cleaved by ASL to generate arginine and fumarate. Arginine is then converted to urea and ornithine by arginase, completing the cycle responsible for eliminating excess nitrogen. Impaired ASS1 activity can disrupt this process, resulting in the accumulation of ammonia and citrulline.
ASS1 also contributes to arginine regeneration outside the urea cycle. In cells expressing nitric oxide synthase, arginine is converted into nitric oxide and citrulline. ASS1 and ASL participate in recycling citrulline into arginine, helping maintain substrate availability for nitric oxide production. This metabolic relationship is relevant to vascular signaling, immune regulation, and cellular responses that depend on nitric oxide synthesis.
Inherited mutations in ASS1 cause citrullinemia type I, an autosomal recessive urea cycle disorder characterized by impaired argininosuccinate formation. Disease manifestations vary according to residual enzyme function and can include hyperammonemia, neurological complications, and metabolic instability. Investigation of ASS1 activity and regulation contributes to understanding the biochemical consequences of disrupted nitrogen metabolism.
ASS1 expression is also important in cancer metabolism. Some tumors exhibit reduced or absent ASS1 expression, limiting their capacity for endogenous arginine synthesis and increasing dependence on extracellular arginine. This metabolic characteristic has been investigated as a potential vulnerability in arginine-deprivation strategies. However, ASS1 expression and its biological significance vary among tumor types and cellular environments.
Argininosuccinate Synthetase 1 Antibody supports research into the regulation of ASS1 expression, arginine metabolism, nitrogen homeostasis, and the metabolic adaptations associated with altered urea cycle activity.
For an alternative reagent with knockout-supported Western blot validation, explore our ASS1 Antibody targeting argininosuccinate synthetase 1.
Titration of the Argininosuccinate Synthetase 1 Antibody / ASS1 Polyclonal Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
A portion of amino acids 192-221 from the human protein was used as the immunogen for this ASS1 antibody.
Aliquot the ASS1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
ASS1 antibody, Argininosuccinate synthetase antibody, Argininosuccinate synthase antibody, Argininosuccinate synthetase type 1 antibody, Citrulline-aspartate ligase antibody, ASS enzyme antibody, ASS1 cytosolic enzyme antibody, Argininosuccinate synthetase 1 protein antibody, ASS1 urea cycle enzyme antibody, ASS1 arginine biosynthesis enzyme antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.